Blockade of indirect recognition mediated by CD4+ T cells leads to prolonged cardiac xenograft survival

Xenotransplantation

Volumn 11, Issue 1, 2004, Pages 33-42

  Singh, Narendra P ^a   Guo, Luping ^a   Que, Xingyi ^a   Shirwan, Haval ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Cardiac grafts; CD4 and CD8 T cells; Immunomodulation; Indirect recognition; Xenotransplantation

Indexed keywords

ANTIBODY; B7 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; SURVIVAL TIME; T LYMPHOCYTE; XENOGRAFT;

ANIMALS; ANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; RATS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0742323552     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2004.00079.x     Document Type: Article

References (52)

1. + T cells in the rat to mouse cardiac xenotransplantation. Transpl Int 1994; 7 (Supp. 1): S654.
2. CASCALHO M, PLATT JL. The immunologic barrier to xenotransplantation. Immunity 2001; 14: 437.
3. CHONG AS, SHEN J, XIAO F et al. Delayed xenograft rejection in the concordant hamster heart into Lewis rat model. Transplantation 1996; 62: 90.
4. + T cells. J Exp Med 1989; 170: 991.
5. MURPHY B, AUCHINCLOSS H Jr, CARPENTER CB, SAYEGH MH. T cell recognition of xeno-MHC peptides during concordant xenograft rejecton. Transplantation 1996; 61: 1133.
6. DORLING A, LOMBARDI G, BINNS R, LECHLER RI. Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population. Eur J Immunol 1996; 26: 1378.
7. STEINBRUCHEL DA, MADSEN HH, LILLEVANG S, NIELSEN B, KEMP E. Anti-CD4 monoclonal antibody treatment combined with total lymphoid irradiation and cyclosporin A in hamster-to-rat cardiac transplantation. Analysis of lymphocyte subsets and anti-donor xenoantibodies. Transpl Immunol 1993; 1: 209.
8. SIMEONOVIC CJ. Xenogeneic islet transplantation. Xenotransplantation 1999; 6: 1.
9. CHONG AS, MA L, YIN D et al. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice. Xenotransplantation 2000; 7: 275.
10. SHIRWAN H, BARWARI L, CRAMER DV. Rejection of cardiac allografts by T cells expressing a restricted repertoire of T-cell receptor Vβ genes. Immunology 1997; 90: 572.
11. SHIRWAN H. Chronic allograft rejection: do the Th2 cells preferentially induced by indirect recognition play a dominant role? Transplantation 1999; 68: 715.
12. BENICHOU G, TAKIZAWA PA, OLSON CA, MCMILLAN M, SERCARZ EE. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175: 305.
13. + T cell and B cell responses after cardiac allografts rejection. Transplantation 1995; 59: 401.
14. WATSCHINGER B, GALLON L, CARPENTER CB, SAYEGH MH. Mechanisms of allo-recognition: recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 1994; 57: 572.
15. FANGMANN J, DALCHAU R, SAWYER GJ, PRIESTLEY CA, FABRE JW. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection. Eur J Immunol 1992; 22: 1525.
16. MATZINGER P, BEVAN MJ. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol 1977; 29: 1.
17. BRAUN MY, MCCORMACK A, WEBB G, BATCHELOR JR. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization. Transplantation 1993; 55: 177.
18. LIU Z, SUN YK, XI YP et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 1993; 177: 1643.
19. CIUBOTARIU R, LIU Z, COLOVAI AI et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998; 101: 398.
20. SIVASAI KSR, SMITH MA, POINDEXTER NJ et al. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Transplantation 1999; 67: 1094.
21. VELLA JP, SPADAFORA-FERREIRA M, MURPHY B et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997; 64: 795.
22. BARZAGA-GILBERT E, GRASS D, LAWRANCE SK et al. Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice. J Exp Med 1992; 175: 1707.
23. MOSES RD, WINN HJ. AUCHINCLOSS H. Evidence that multiple defects in cell-surface molecule interactions across species differences are responsible for diminished xenogeneic T cell responses. Transplantation 1992; 53: 203.
24. ALTER BJ, BACH FH. Cellular basis of the proloferative response of human cells to mouse xenoantigens. J Exp Med 1990; 171: 333.
25. LUCAS PJ, SHEARER GM, NEUDORF S, GRESS RE. The human antimurine cenogeneic cytotoxic response: I. dependence on responder antigen-presenting cells. J Immunol 1990; 144: 4548.
26. + helper T cells and self antigen-presenting cells in the mouse. J Exp Med 1990; 172: 567.
27. + T cell clones. Transplantation 1998; 65: 706.
28. BENFIELD MR, WITSON JC, ALTER BJ, BACH FH. Murine APC activation in the xenogeneic MLC. Scand J Immunol 1993; 38: 130.
29. DORLING A, BINNS R, LECHLER RI. Cellular xenoresponses: observation of significant primary indirect human T cell anti-pig xenoresponses using co-stimulator-deficient or SLA class II-negative porcine stimulators. Xenotransplantation 1996; 3: 112.
30. + indirect response. Xenotransplantation 1998; 5: 93.
31. CHITILIAN HV, AUCHINCLOSS HJ. Studies of transplantation immunology with major histocompatibility complex knockout mice. J Heart Lung Transplant 1997; 16: 153.
32. OZATO K, SACHS DH. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. J Immunol 1981; 126: 317.
33. BENICHOU G, FEDOSEYEVA E, LEHMANN PV et al. Limited T cell response to donor MHC peptides during allograft rejection. J Immunol 1994; 153: 938.
34. , LARSEN CP, ELWOOD ET, ALEXANDER DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
35. SCHWARTZ RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71: 1065.
36. HATHCOCK KS, LASZLO G, PUCILLO C, LINSLEY P, HODES RJ. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 1994; 180: 631.
37. HANCOCK WW, SAYEGH MH, ZHENG XG et al. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 1996; 93: 13967.
38. MANDELBROT DA, KISHIMOTO K, AUCHINCLOSS H Jr, SHARPE AH, SAYEGH MH. Rejection of mouse cardiac allografts by costimulation in trans. J Immunol 2001; 167: 1174.
39. + and CD8+ T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity. J Immunol 1999; 163: 3239.
40. KANO M, BASHUDA H, YAGITA H, OKUMURA K, MORISHITA Y. A crucial role of host CD80 and CD86 in rat cardiac xenograft rejection in mice. Transplantation 1998; 65: 837.
41. + cells. Transplantation 2001; 71: 319.
42. MCKENZIE AW, GEORGIOU HM, ZHAN Y, BRADY JL, LEW AM. Protection of xenografts by a combination of immunoisolation and a single dose of anti-CD4 antibody. Cell Transplant 2001; 10: 183.
43. BENICHOU G, VALUJSKIKH A, HEEGER PS. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999; 162: 352.
44. LEE RS, YAMADA K, WOMER KL et al. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses. J Immunol 2000; 164: 3434.
45. ITESCU S, KWIATKOWSKI P, ARTRIP JH et al. Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Hum Immunol 1998; 59: 275.
46. KWIATKOWSKI P, ARTRIP JH, ANKERSMIT J et al. Importance of CD49d-VCAM interactions in human monocyte adhesion to porcine endothelium. Xenotransplantation 1998; 5: 67.
47. ROGERS SN, MIRANDA V, JACKSON I, DORLING A, LECHLER RI. Costimulatory blockade by the induction of an endogenous xenospecific antibody response. Nat Immunol 2000; 2: 163.
48. SAYEGH MH, KHOURY SJ, HANCOCK WW, WEINER HL. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex antigens in the rat. Proc Natl Acad Sci USA 1992; 89: 7762.
49. MHOYAN A, CRAMER DV, BAQUERIZO A, SHIRWAN H. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides: 1. correlation of graft survival with anti-donor IgG antibody subclasses. Transplantation 1997; 64: 1665.
50. SHIRWAN H, WU GD, BARWARI L, LIU A, CRAMER DV. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. II. Evidence for persistent chronic rejection despite high levels of donor microchimerism. Transplantation 1997; 64: 1671.
51. CHOWDHURY NC, SABORIO DV, GARROVILLO M et al. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide. Transplantation 1998; 66: 1059.
52. CHEN W, SAYEGH MH, KHOURY SJ. Mechanisms of acquired thymic tolerance in vivo: intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell energy. J Immunol 1998; 160: 1504.